K. Katayama

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

Sonoko Misawa, Satoshi Kuwabara, Yasunori Sato et al. · The Lancet Neurology · 2018 · 161 citations

Medicine, Neurology, Pharmacotherapy +4

Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial

Sonoko Misawa, Yasunori Sato, K. Katayama et al. · The Lancet Neurology · 2016 · 79 citations

Humanities, Pharmacology, Pharmacotherapy +4

Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study

Sonoko Misawa, Yasunori Sato, K. Katayama et al. · BMJ Open · 2015 · 67 citations · Full text

Medicine, Endocrinology, Neurology +13

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

Nobuko Yamaguchi, Sonoko Misawa, Yasunori Sato et al. · JMIR Research Protocols · 2016 · 25 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +17

Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial

K. Katayama, Sonoko Misawa, Yasunori Sato et al. · BMJ Open · 2015 · 14 citations · Full text

Medicine, Neurology, Pharmacology +11